KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
9.00
+0.04 (0.45%)
Nov 21, 2024, 1:44 PM EST - Market open
KalVista Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Nov '24 Nov 21, 2024 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 | Apr '21 Apr 30, 2021 | Apr '20 Apr 30, 2020 |
| Market Capitalization | 389 | 479 | 291 | 312 | 607 | 195 | |
| Market Cap Growth | 79.71% | 64.29% | -6.71% | -48.53% | 211.76% | -50.92% | |
| Enterprise Value | 219 | 411 | 128 | 126 | 558 | 116 | |
| Last Close Price | 8.96 | 11.35 | 8.53 | 12.73 | 24.97 | 10.91 | |
| PS Ratio | - | - | - | - | - | 15.34 | |
| PB Ratio | 2.23 | 2.32 | 1.81 | 1.69 | 2.36 | 2.32 | |
| P/TBV Ratio | 3.60 | 2.32 | 1.81 | 1.69 | 2.36 | 2.32 | |
| EV/Sales Ratio | - | - | - | - | - | 9.11 | |
| Debt / Equity Ratio | 0.04 | 0.04 | 0.05 | 0.04 | 0.02 | 0.02 | |
| Asset Turnover | - | - | - | - | - | 0.12 | |
| Quick Ratio | 8.32 | 9.70 | 11.18 | 15.81 | 26.67 | 10.91 | |
| Current Ratio | 8.55 | 9.90 | 11.46 | 16.73 | 27.04 | 11.49 | |
| Return on Equity (ROE) | -90.84% | -68.90% | -53.69% | -37.23% | -27.13% | -32.26% | |
| Return on Assets (ROA) | -53.94% | -41.94% | -35.80% | -25.38% | -19.86% | -24.05% | |
| Return on Capital (ROIC) | -59.58% | -45.82% | -38.23% | -26.46% | -20.78% | -27.81% | |
| Earnings Yield | -36.61% | -26.45% | -31.88% | -26.35% | -7.62% | -14.95% | |
| FCF Yield | -26.54% | -18.64% | -26.23% | -25.31% | -4.98% | -23.13% | |
| Buyback Yield / Dilution | -30.92% | -31.89% | -13.97% | -28.17% | -7.58% | -17.69% | |
| Total Shareholder Return | -30.92% | -31.89% | -13.97% | -28.17% | -7.58% | -17.69% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.